Evolution of the Average Target: MedCap AB

Evolution of the Average Target - MedCap AB

Evolution of the Target Price: MedCap AB

Evolution of the Target Price - MedCap AB

Changes in Analyst Recommendations: MedCap AB

b4.QZRpjWYvacRl_4DGR6T3q-I44oCrkQcjAudB_U15Qog.N-MawhVWAqkRk9mwBJGo9K1B1ffp30BtZdJ2qxJAcfoj5Fq7VnAfhyq0sA~d2cfe66921df7f771e43e6162ba3abea
10-09 SEB cuts Medcap price target but reiterates buy FW
10-09 SEB cuts its price target for Medcap to SEK 615 (660), reiterates Buy FW
07-22 SEB raises Medcap price target to 660 kronor (630), reiterates buy FW
06-30 SEB raises Medcap price target to 630 kronor (590), reiterates buy FW
06-24 Affärsvärlden issues a buy recommendation for Medcap FW
05-13 Medcap rated 'Buy' by EFN FW
04-29 SEB raises Medcap price target to SEK 590 (570), reiterates Buy FW
03-31 SEB cuts Medcap price target to SEK 570 (615), reiterates Buy FW
02-06 SEB Lowers Price Target for Medcap to 615 Kronor (650), Reiterates Buy FW
12-18 SEB Lowers Target Price for Medcap to 650 Kronor (700), Reiterates Buy FW
27/10/25 SEB Raises Target Price for Medcap to 700 Kronor (660), Reiterates Buy FW
24/10/25 MedCap AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
09/09/25 SEB Raises Target Price for Medcap to SEK 660 (from 550), Reiterates Buy - BN FW
01/07/25 SEB raises target price for Medcap to SEK 550 (515), reiterates buy recommendation FW
25/06/25 Affärsvärlden Issues Neutral Recommendation for Medcap Following Danish Acquisition FW
29/04/25 SEB raises target price for Medcap to SEK 515 (485), reiterates buy recommendation FW
02/04/25 SEB lowers target price for Medcap to SEK 485 (515), reiterates Buy - BN FW
31/01/25 SEB lowers target price for Medcap to SEK 515 (650), reiterates Buy - BN FW
17/01/25 Affärsvärlden gives a neutral advice for Medcap after the profit warning FW
17/01/25 Bank of Åland expects strong negative price reaction in Medcap FW
10/01/25 Aktiespararna puts buy on Medcap with target price SEK 720 FW
17/12/24 SEB raises target price for Medcap to SEK 650 (575), reiterates Buy - BN FW
05/11/24 Redeye initiates coverage on Medcap - fairly valued at present (R) FW
04/11/24 Redeye initiates coverage on Medcap - fairly valued at present FW
04/11/24 Redeye initiates coverage on Medcap with motivated value of SEK 535 per share in base case FW

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +19.07%
+19.12%
+14.82%
+14.67%
+30.43%
+32.62%
+39.9%
+19.23%
+34.02%
+16.24%
Average +24.01%
Weighted average by Cap. +23.27%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
539.50SEK
Average target price
640.00SEK
Spread / Average Target
+18.63%
High Price Target
660.00SEK
Spread / Highest target
+22.34%
Low Price Target
620.00SEK
Spread / Lowest Target
+14.92%

Analyst Consensus Detail

Analyst consensus - MedCap AB

Consensus revision (last 18 months)

Consensus revision (last 18 months) - MedCap AB
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
AAA
MarketScreener Ratings - MedCap AB